NEOPLASMS BY SITE
Clinical trials for NEOPLASMS BY SITE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY SITE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New targeted pill takes on chemo for rare lung cancer
Disease control TerminatedThis study tested a new targeted drug, pralsetinib, against standard chemotherapy in people with a specific type of advanced lung cancer (RET fusion-positive) who had not yet received treatment for their metastatic disease. The goal was to see if pralsetinib could better delay ca…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 01, 2026 15:29 UTC
-
Kidney cancer drug combo trial halted early
Disease control TerminatedThis study tested a new drug (NKT2152) combined with two other medicines (palbociclib and sasanlimab) in people with advanced clear cell kidney cancer that had gotten worse after prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial …
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC